Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 2, 2002, Pages 433-441

  Wittmann, Marion ^a,b,c   Marino, Michael J ^a,b,c   Jeffrey Conn, P ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINOBUTYRIC ACID RECEPTOR; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; EGLUMETAD; HALOPERIDOL; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; PRESYNAPTIC RECEPTOR; QUINPIROLE; RECEPTOR SUBTYPE; RESERPINE; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN SLICE; CELL ACTIVATION; CONTROLLED STUDY; DENDRITE; DOPAMINERGIC TRANSMISSION; GABAERGIC SYSTEM; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PATCH CLAMP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; SYNAPTIC TRANSMISSION;

ANIMALS; BENZAZEPINES; BICYCLO COMPOUNDS; DOPAMINE; DOPAMINE AGONISTS; EXCITATORY AMINO ACID AGONISTS; HALOPERIDOL; NEURONS; RATS; RECEPTORS, METABOTROPIC GLUTAMATE; SUBSTANTIA NIGRA; SULPIRIDE; SYNAPTIC TRANSMISSION;

EID: 0036076705     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.033266     Document Type: Article

References (42)

1. Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: In vivo microdialysis studies
2. D-1 receptor mediated modulation of the release of gamma-aminobutyric acid by endogenous dopamine in the basal ganglia of the rat
3. Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems
4. Dopamine in dendrites of substantia nigra neurons: Suggestions for a role in dendritic terminals
5. Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia nigra pars reticulata
6. Cyclic AMP-dependent protein kinase phosphorylates group III metabotropic glutamate receptors and inhibits their function as presynaptic receptors
7. 2 receptor knockout mice
8. Dendritic release of dopamine in the substantia nigra
9. Primate models of movement disorders of basal ganglia origin
10. Reserpine-insensitive dopamine release in the substantia nigra
11. Substantia nigra
12. Adenosinedopamine interactions in the brain
13. 1 receptor interactions in the basal ganglia
14. Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata
15. Release of dopamine from dendrites in rat substantia nigra
16. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
17. Morphology of the substantia nigra pars reticulata projection neurons intracellularly labeled with HRP
18. Biochemistry of somatodendritic dopamine release in substantia nigra: An in vivo comparison with striatal dopamine release
19. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output
20. Phorbol ester and forskolin suppress the presynaptic inhibitory action of group-II metabotropic glutamate receptor at rat hippocampal mossy fiber synapse
21. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats
22. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists
23. Protein kinase C and A3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins
24. D1 agonist-induced excitation of substantia nigra pars reticulata neurons: Mediation by D1 receptors on striatonigral terminals via a pertussis toxin-sensitive coupling pathway
25. Dopamine D2, receptor-mediated modulation of the GABA-ergic inhibition of substantia nigra pars reticulata neurons
26. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): Studies of tremulous jaw movements in rats
27. Mechanisms of multifunctional signalling by G protein-linked receptors
28. Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata
29. Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata
30. Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro
31. Electrophysiological and immunocytochemical characterization of GABA and dopamine neurons in the substantia nigra of the rat
32. Receptors fro dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity
33. Reciprocal interaction between glutamate and dopamine in the pars reticulata of the rat substantia nigra: A microdialysis study
34. The regulation of dopamine release from nigrostriatal neurons in conscious rats: The role of somatodendritic autoreceptors
35. cAMP-dependent protein kinase inhibits mGluR2 coupling to G-proteins by direct receptor phosphorylation
36. Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys
37. Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat
38. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons
39. Models of basal ganglia function and pathophysiology of movement disorders
40. Improved therapies for Parkinson's disease: Life beyond dopamine D2/D3 receptor agonists
41. Activation of group III mGluRs inhibits GABA-ergic and glutamatergic transmission in the substantia nigra pars reticulata
42. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy